Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma.

ABSTRACT:

SUBMITTER: Kudo M 

PROVIDER: S-EPMC6249592 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature